Description
To enhance the health of Canadians and health system sustainability by promoting the cost-effective and optimal use of drugs and other health technologies.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #22024-02-09$20,597,323
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2024-02-09 | $20,597,323 | — | To enhance the health of Canadians and health system sustainability by promoting the cost-effective and optima… |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (business number 132633868)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 271-2024-2025-Q1-00004 | Health Canada | Santé Canada · Contribution to the Canadian Agency for Drugs and Technologies in Health | $91,576,307 | FY2024 |
| 271-2024-2025-Q2-00019 | Health Canada | Santé Canada · Contribution to the Canadian Agency for Drugs and Technologies in Health | $140,100,307 | FY2024 |
| 271-2024-2025-Q4-00111 | Health Canada | Santé Canada · Contribution to the Canadian Agency for Drugs and Technologies in Health | $265,276,781 | FY2024 |
| 271-2021-2022-Q4-00111 | Health Canada | Santé Canada · Canadian Health Systems and Programs | $19,797,323 | FY2022 |
| 271-2023-2024-Q3-00034 | Health Canada | Santé Canada · Contribution to the Canadian Agency for Drugs and Technologies in Health | $153,378,237 | FY2018 |
| 271-2022-2023-Q4-00163 | Health Canada | Santé Canada · Contribution to the Canadian Agency for Drugs and Technologies in Health | $150,352,614 | FY2018 |
Cite as: Glassbox record view · Federal grants & contributions · 271-2023-2024-Q4-00077 · retrieved 2026-11-12.